Evidence map›Paper›PMID 33613827›Full record

ArticleOxidative medicine and cellular longevity2021

Characterization and Hepatoprotections of

Yiwen Zhang, Yanbo Feng, Wenshuai Wang, Le Jia, Jianjun Zhang

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in immunology · 2026
    Article
  4. Review
  5. Review
  6. Improvement ofMolecules (Basel, Switzerland) · 2024
    Article
  7. Heliyon · 2024
    Review
  8. Article
  9. Unraveling the Polysaccharide Biosynthesis Potential ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Article
  12. Frontiers in veterinary science · 2023
    Article
  13. Frontiers in pharmacology · 2023
    Article
  14. Article
  15. Review
  16. Peroxidase-Like Platinum Clusters Synthesized byMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yiwen ZhangCollege of Life Science, Shandong Agricultural University, Taian 271018, China.
Yanbo FengCollege of Life Science, Shandong Agricultural University, Taian 271018, China.
Wenshuai WangCollege of Life Science, Shandong Agricultural University, Taian 271018, China.
Le JiaCollege of Life Science, Shandong Agricultural University, Taian 271018, China.
Jianjun ZhangCollege of Life Science, Shandong Agricultural University, Taian 271018, China.ORCID https://orcid.org/0000-0001-6168-5988
Shandong Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe liver is one of the most commonly affected organs in multiple organ dysfunction syndrome (MODS). In recent years, there have been many studies on

methodsThe characteristic properties of GLP were processed by physicochemical analysis. The MODS models were successfully established with intraperitoneal injection of zymosan in Kunming strain mice. The antioxidant, anti-inflammatory, and hepatoprotective effects of GLP were processed both

resultsThe characterization analysis revealed that GLP was a pyranose mainly composed of glucose with the molecular weights (Mw) of 8309 Da. The experimental results proved that GLP had potential hepatoprotection possibly by improving the antioxidant status (scavenging excessive oxygen radicals, increasing the antioxidant enzyme activities, and reducing the lipid peroxide), alleviating the inflammatory response (reducing the inflammatory factor levels), and guaranteeing the liver functions.

conclusionsThis research suggested that GLP had the potential to be developed as a natural medicine for the treatment of multiple organ failure.

Indexed as

Alanine TransaminaseAlkaline PhosphataseAnimalsAntioxidantsAspartate AminotransferasesCatalaseCyclooxygenase 2CytokinesDinoprostoneInflammation MediatorsLiverMaleMalondialdehydeMiceMultiple Organ FailurePolysaccharidesAlanine TransaminaseAlkaline PhosphataseAntioxidantsAspartate AminotransferasesCatalaseCyclooxygenase 2CytokinesDinoprostoneInflammation MediatorsMalondialdehydePolysaccharidesProtective AgentsSuperoxide Dismutase

Identifiers

PMID33613827
PMCPMC7876828
OpenAlexW3126820195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.